Hennion & Walsh Asset Management’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,764
| Closed | -$225K | – | 920 |
|
|
2025
Q1 | $225K | Sell |
7,764
-175
| -2% | -$5.07K | 0.01% | 809 |
|
|
2024
Q4 | $295K | Sell |
7,939
-93
| -1% | -$3.45K | 0.01% | 763 |
|
|
2024
Q3 | $390K | Sell |
8,032
-55
| -0.7% | -$2.67K | 0.02% | 678 |
|
|
2024
Q2 | $323K | Sell |
8,087
-147
| -2% | -$5.88K | 0.02% | 707 |
|
|
2024
Q1 | $362K | Sell |
8,234
-3,022
| -27% | -$133K | 0.02% | 643 |
|
|
2023
Q4 | $696K | Buy |
11,256
+2,328
| +26% | +$144K | 0.04% | 486 |
|
|
2023
Q3 | $411K | Buy |
8,928
+2,050
| +30% | +$94.3K | 0.03% | 574 |
|
|
2023
Q2 | $395K | Sell |
6,878
-104
| -1% | -$5.97K | 0.02% | 579 |
|
|
2023
Q1 | $262K | Buy |
+6,982
| New | +$262K | 0.02% | 680 |
|
|
2022
Q4 | – | Sell |
-7,286
| Closed | -$205K | – | 769 |
|
|
2022
Q3 | $205K | Buy |
+7,286
| New | +$205K | 0.01% | 712 |
|